期刊文献+

福建地区人乳头瘤状病毒流行病学调查研究 被引量:4

The epidemiologic study on human papillomavirus in Fujian province of China
暂未订购
导出
摘要 目的明确福建地区无症状女性人群宫颈人乳头瘤状病毒(HPV)的感染现状,指导相关预防性疫苗的接种。方法采用流式荧光杂交法对2011年3月至2012年3月采集的3 052例健康体检女性人群宫颈脱落细胞样本进行分型检测。结果总HPV感染率为11.3%,高危型HPV感染率为10.4%,感染前5位的型别分别为HPV-52(2.3%),HPV-58(1.7%),HPV-16(1.6%),HPV-18(0.8%),HPV-68(0.7%)。HPV感染年龄分布存在双峰现象,20~24岁年龄组的HPV-16感染率明显较高。结论福建地区无症状女性人群中,HPV-52及HPV-58的感染率相对较高,提示包含HPV-52及HPV-58的第2代预防性疫苗能为福建地区女性提供更好的保护。HPV感染存在2个年龄高峰,对疫苗的适用具有指导意义。对有性生活的年轻女性进行普遍的包含HPV-16的预防性疫苗的补救性接种会获得较大收益。 Objective To clear Fujian region in asymptomatie women with cervical human papillomavirus virus (HPV) infection status for guidance to the relevant preventive vaccines targeted. Methods 3 052 healthy women cervical exfoliated cell samples were detected by flow fluorescence hybridization methods from March 2011 to March 2012. Results The total rate of HPV infection was 11.3 %, high-risk HPV infection rate was 10.4 %/00, the infection ranked top five types were HPV-52 (2.3 % ), HPV-58 ( 1.7 % ), HPV-16 ( 1.6 % ), HPV-18 (0.8 % ), HPV-68 (0.7 % ) respectively. HPV infection age distribution was the presence of Shuangfeng phenomenon. 20- 24 years old age group,HPV-16 infection rate increased significantly. Conclusion Fujian region in asymptomatie female popuLation, HPV-52and HPV-58 infection rates are relatively high,suggests than the second generation of prophylactic vaccines contains HPV-52and HPV-58 have higher probability of protection for women in Fujian area. Fujian region in asymptomatic female population, HPV infection has presence of two age peaks, this vaccine has guiding significance to apply. It can gain bigger profit to launeh preventive vaccine remedial inoculation which contains HPV-16 for sexual life of young women.
出处 《检验医学与临床》 CAS 2012年第24期3099-3101,共3页 Laboratory Medicine and Clinic
关键词 人乳头瘤状病毒 流行病学 预防性疫苗 humanpapillomavirus Virus epidemiology vaccine
  • 相关文献

参考文献17

  • 1Bosch FX,Manos MM, Munoz N, et al. Prevalence of hu- man papillomavirus in cervical cancer: a worldwide per- spective. International biological study on cervical cancer (IBSCC) Study Group[J]. J Natl Cancer Inst, 1995,87 (11) :796-802.
  • 2Munoz N,Castellsague X,de Gonzalez AB,et al. Chapter 1: HPV in the etiology of hunan cancer[J]. Vaccine, 2006,24(13): 1-10.
  • 3Herrero R. Human papillomavirus(HPV) vaccines., limit- ed cross-protection against additional HPV types[J]. J In- fect Dis, 2009,199 (7): 919-922.
  • 4Syljanen S, Shabalova IP, papilloma virus testing and ogy as optional screening risks for cervical cancer in Soviet Unioni J Low Genit Petrovichev N, et al. Human conventional Pap smear cytol- tools of women at different Countries of the former[J]. Tract Dis, 2002,6 : 97-110.
  • 5Tsai HJ, Wu CH, Lai HL, et al. Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk [J]. Cancer Epidemiol Biomarkers Prev,2005,14(11) :2544-2549.
  • 6Kjaer SK,Sigurdsson K,Iversen OE,et al. A pooled anal- ysis of continued prophylactic efficacy of quadrivalent hu- man papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions[J]. Cancer Prey Res(Phila Pa), 2009,2 (10) : 868-878.
  • 7Chan PK, Ho WC, Wong MC, et al. Epidemiologic risk profile of infection with different groups of human papil- lomaviruses[J]. J Med Virol, 2009,81 (9) : 1635-1644.
  • 8Clifford GM, Gallus S, Herrero R,et al. Worldwide distri- bution of human papillomavirus types in cytologically nor- mal women in the International Agency for Research on Cancer HPV prevalence surveys: a plloed analysis [J]. Lancet, 2005,366 (9490) :991-998.
  • 9Dai M,Bao YO,Li N, et al. Human papillomavirus infec- tion in Shanxi Province, Peopler s Republic of China: a popuLation-based study[J]. Br J Cancer, 2006,95 ( 1 ) : 96- 101.
  • 10Li LK,Dai M, Clifford GM, et al. Human papillomavirus infection in Shenyang city,People's Republic of China.. a popuLation-based study[J]. Br J Cancer, 2006,95 (11): 1593-1597.

二级参考文献7

  • 1Manos MM,Waldeman J,Zhang TY,et al.Epidemiology and particalnucleotide sequence of four novel genital human papillomavirus[J].J Infent Dis,1994,170:1096.
  • 2Burk RD,Ho GY Beardsley L,et al.Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection inyoungwomen[J].InfeetDis,1999,174:679-689.
  • 3Zur Hausen H,De Villers EM.Human papillomaviruses[J].Annu Rev Microbiol,1994,48:427.
  • 4Pagliusi SR,Aguado MT.Efficacy and other milestones for human papiIlomavirus vaccine introduction[J].Vaccine,2004,23:569.
  • 5Mclachlin CM.Human papillomavirus in cervical neroplasia.Role,risk factors and implications[J].Clin LabMed,2000,20:257-270.
  • 6Saslow D,Runowicz CD,Solomon D,et al.American cancer socie guideline for the early detection of cervicalneoplasia and cancer[J].Cancer J CIin,2002,52:342-362.
  • 7李连青,朱庆义,郑曙民.聚合酶链反应酶谱分型检测宫颈癌中人乳头瘤病毒和单纯疱疹病毒[J].中华实验和临床病毒学杂志,1999,13(3):235-238. 被引量:21

共引文献11

同被引文献22

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部